Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
This has been a bad decision for me to come here. I had a very stable great paying job. This company is a rollercoaster.
What is most positive about the culture and environment at your company?
My coworkers are really smart and insightful
What are some of the best things about your team?
We all know we are in it together
Why do you feel undervalued and what would make you feel better about your compensation?
The bonus plan for HOS’s is terrible. Even high volume
What's going wrong and how can it be improved?
Manager micromanaging. Texts and calls after hours. Treats us like we are idiots.
What does the leadership team need to get better at?
Understanding the limits of marketability of xpovio in a crowed space with really good other options. Covid and the fact that the market doesn?
Other Employee Reviews for Karyopharm Therapeutics
×